DOCUMENT 3 FOI 24/25-0638 OFFICIAL: SENSITIVE
ATTACHMENT B: Sustainability Impact Assessment of the 2021-22 Annual Pricing Review
2021-22 Annual Pricing Review
This attachment considers the recommendations from the 2021-22 Annual Pricing Review and
provides a high level estimate of the impact on Scheme costs compared to if the
recommendations were not implemented. Various scenarios for the following recommendations
have been considered:
redacted: s22(1)(a)(ii) - irrelevant material
- no increase to price limits for therapy supports at 1 July 2022
redacted: s22(1)(a)(ii) - irrelevant material
Assumptions
redacted: s22(1)(a)(ii) - irrelevant material
-
The cost impact for changes in the price limits for therapy and plan management supports are calculated by removing or increasing the assumed non-SCHADS indexation for labour costs of 1.75% in the AFSR.
-
Zero price indexation has been applied to therapy supports (i.e. Capacity Building Daily Activities and Capacity Building Health and Wellbeing) and plan management supports (i.e. Capacity Building Choice and Control).
redacted: s22(1)(a)(ii) - irrelevant materialOFFICIAL: SENSITIVE 4.2.1b.1 Page 6 of 134
OFFICIAL: SENSITIVE
redacted: s22(1)(a)(ii) - irrelevant material
*
Impact of Proposal
| Impact ($m) | 2022/23 | 2023/24 | 2024/25 | 2025/26 | Total |
|---|---|---|---|---|---|
redacted: s22(1)(a)(ii) - irrelevant material |
|||||
| Therapy price limits | |||||
| 0% increase on 1 July 2022 | -$67m | -$75m | -$81m | -$87m | -$310m |
redacted: s22(1)(a)(ii) - irrelevant material |
-
0% increase for therapy and plan management on 1 July 2022
-
-redacted: s22(1)(a)(ii) - irrelevant material``OFFICIAL: SENSITIVE 4.2.1b.2 Page 7 of 134